Your allergy
What is allergy
House dust mite allergy
Pollen allergy
Living with allergy
Socio-economic impact
What is allergic asthma
How is allergy diagnosed
Treating allergy
Our solutions
Consumer healthcare
Diagnostics
Allergy vaccines
Production
Emergency medicine
Our science
Scientific focus
Science & technology
Pipeline
Digital innovation
Clinical data sharing
Collaboration & partnerships
Healthcare Professionals
Allergy Immunotherapy
Reweal
Clinical trials
Webinars
The Henning Lowenstein Research Award
Our company
Newsroom
Stories
Privacy
Global presence
Organisation
History
Owners
Sustainability
Investors
Overview
Financial reporting
Risk management
Reporting standards
Auditors
Governance
Executive Leadership Team
Board of Directors
News & Events
Company Releases
Company releases (DK)
Webcasts & presentations
Investor calendar
Capital Markets Day 2024
The Share
Dividend history
Analyst coverage
Analyst estimates
Shareholder information
Authorizations
Contact IR
Annual general meeting
Annual general meeting (DK)
Capital Markets Day 2024
Careers
Working at ALK
Vacant positions
Cultural Beliefs
Select country
Fulltext search
Search
Event details
«
Back
Three-month interim report (Q1) 2025
May 6, 2025
Add to Outlook
Add to Google Calendar
Email Alerts
Email Alerts
Downloads
Downloads
RSS
RSS
Print
Print
Share
Share
English
English
Search
Search